German medical technology firm Brainlab said on Monday it had set the price range for its initial public offering (IPO) at 80 ...

BERLIN (Reuters) -German medical technology firm Brainlab set the price range for its initial public offering at 80 to 100 ...

Brainlab, the German medical technology company, set the price range for its forthcoming IPO at €80 to €100 a share on Monday ...

Medical technology software firm Brainlab AG and its shareholders are seeking up to €400 million ($460 million) in its Frankfurt initial public offering, as several European companies look to list ...

All websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

In its provisional prospectus, the start-up says the proceeds of the IPO will go towards phase 2a trials of OD-07656, its small molecule RIPK2 inhibitor. To date, most effort by the pharma ...

xAI remains privately held, not tradable publicly; accredited investors can buy pre-IPO shares via secondary markets. Investment opportunities in AI include buying shares of firms like Nvidia ...

Investors must wait for a possible Wayve IPO or explore alternative autonomous mobility stocks like Nvidia or Tesla. ETFs offer exposure to autonomous vehicle tech, with options like iShares Self ...

Digital therapeutics (DTx) developer Hinge Health has published a new prospectus for an initial public offering (IPO) in the US, shrugging off the weakness in stock markets caused by President ...